HCA Announces 30 Million Share Sponsor Secondary Offering And Concurrent Company $500 Million Share Repurchase From Sponsors
HCA Holdings, Inc. (the “Company”) (NYSE: HCA) today announced that
certain of its stockholders, consisting principally of affiliates of, or
funds sponsored by, Bain Capital Partners, LLC and Kohlberg Kravis
HCA Holdings, Inc. (the “Company”) (NYSE: HCA) today announced that certain of its stockholders, consisting principally of affiliates of, or funds sponsored by, Bain Capital Partners, LLC and Kohlberg Kravis Roberts & Co. (the “Selling Stockholders”), intend to offer for sale in an underwritten secondary offering 30 million shares of its common stock pursuant to the Company’s shelf registration statement filed with the Securities and Exchange Commission. The Selling Stockholders will receive all of the proceeds from this offering. No shares are being sold by management or the Company. The last reported sale price of the Company’s common stock on October 29, 2013 was $47.34 per share. The offering is expected to close on November 1, 2013, subject to customary closing conditions. Conditional upon and concurrent with the closing of the offering, the Company has agreed to repurchase approximately $500 million of additional shares of its common stock from the Selling Stockholders at the net offering price. Goldman, Sachs & Co. will act as underwriter for the offering. The Company has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the Company has filed with the SEC for more complete information about the Company and this offering. You may obtain these documents for free by visiting EDGAR on the SEC Web site at: www.sec.gov. Alternatively, copies of the prospectus supplement and accompanying prospectus relating to the offering, when available, may be obtained from: Goldman, Sachs & Co., Attention: Prospectus Department, 200 West Street, New York, NY 10282, telephone at (866) 471-2526, or by facsimile at (212) 902-9316 or by emailing email@example.com. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.